Journal of Pharmacopuncture (대한약침학회지)

KOREAN PHARMACOPUNCTURE INSTITUTE (대한약침학회)
권호 표지
DOI QR코드

DOI QR Code

Evaluation of Genotoxicity of SU-Eohyeol Pharmacopuncture Using an In Vitro Chromosome Aberration Test in Chinese Hamster Lung Cell

  • Ku, Jaseung (Bogwang Korean Medical Clinic) ;
  • Hwang, Ji Hye (Department of Acupuncture & Moxibustion Medicine, College of Korean Medicine, Gachon University)
  • Received : 2022.07.09
  • Accepted : 2022.08.08
  • Published : 2022.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: This study was conducted to evaluate the safety of SU-Eohyeol pharmacopuncture (SUEP) by assessing its potential to cause chromosomal abnormalities in Chinese hamster lung cells (CHL/IC). Methods: A dose-curve was conducted to determine the highest dose of SUEP. Doses of 10, 5, 2.5, 1.25, 0.625, and 0.313% were used, and no cytotoxicity or SUEP precipitation was observed. SUEP doses of 10, 5, and 2.5%, with positive and negative controls, were used in a chromosome aberration test. Results: In this study, the frequency of abnormal chromosomal cells in the SUEP group did not show a statistically significant difference from that of the negative control group in short-term treatments with and without metabolic activation and the continuous treatment without metabolic activation. Compared with the negative control group, the positive control group had a significantly higher frequency of cells with structural chromosomal abnormalities. This test's results satisfied all conditions for determining the results. Conclusion: SUEP did not induce chromosomal aberrations under the conditions of this study. Other toxicity evaluations, safety studies in humans, and various clinical trials are required to evaluate the safety and efficacy of SUEP.

Keywords

Acknowledgement

This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. NRF-2022R1A2C1013518).

References

  1. Lee MY, Seo CS, Kim JY, Shin HK. Genotoxicity evaluation of Guibi-Tang extract using an in vitro bacterial reverse mutation assay, chromosome aberration assay, and in vivo micronucleus test. BMC Complement Altern Med. 2014;14:215. https://doi.org/10.1186/1472-6882-14-215
  2. Timoroglu I, Yuzbasioglu D, unal F, Yilmaz S, Aksoy H, Celik M. Assessment of the genotoxic effects of organophosphorus insecticides phorate and trichlorfon in human lymphocytes. Environ Toxicol. 2014;29(5):577-87. https://doi.org/10.1002/tox.21783
  3. Yuzbasioglu D, Celik M, Yilmaz S, Unal F, Aksoy H. Clastogenicity of the fungicide afugan in cultured human lymphocytes. Mutat Res. 2006;604(1-2):53-9. https://doi.org/10.1016/j.mrgentox.2006.01.001
  4. Rama RP, Kaul CL, Jena GB. Genotoxicity testing, a regulatory requirement for drug discovery and development: impact of ICH guidelines. Indian J Pharmacol. 2002;34(2):86-9.
  5. Jung C, Jung JH, Lee MS. A clinical study of immune pharmacopuncturology. Chungnam: Kyungrak Medical Publishing Co.; 2011. 523 p.
  6. Korean Acupuncture and Moxibustion Medicine Society. Acupuncture medicine. Seoul: Hanmi Medical Publishing Co.; 2020. 932 p.
  7. Sung SH, Shin BC, Park MJ, Kim KH, Kim JW, Ryu JY, et al. Current status of management on pharmacopuncture in Korea through introduction of an accreditation system. J Pharmacopuncture. 2019;22(2):75-82. https://doi.org/10.3831/KPI.2019.22.009
  8. Woo SH, Lee JH, Lee CI, Lee YK, Lee HJ, Kim JS. Single-dose and 4-week repeated dose toxicity of Aconitum Sinomontanum Nakai pharmacopuncture: an experimental study. J Acupunct Res. 2021;38(1):47-59. https://doi.org/10.13045/jar.2020.00332
  9. Ren Y, Zhang P, Yan D, Wang J, Du X, Xiao X. A strategy for the detection of quality fluctuation of a Chinese herbal injection based on chemical fingerprinting combined with biological fingerprinting. J Pharm Biomed Anal. 2011;56(2):436-42. https://doi.org/10.1016/j.jpba.2011.05.006
  10. Park JE. A survey on Korean medicine doctor's use of Herbal Acupuncture and recognition of its national health insurance coverage [master's thesis]. [Seoul]: Kyung Hee University; 2018. 68 p.
  11. Yoon JW, Kim SJ. A review of clinical study on Jungsongouhyul pharmacopuncture treatment published in Korea. J Korean Med Rehabil. 2017;27(4):75-84. https://doi.org/10.18325/jkmr.2017.27.4.75
  12. Kirkland D, Aardema M, Henderson L, Muller L. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity. Mutat Res. 2005;584(1-2):1-256. https://doi.org/10.1016/j.mrgentox.2005.02.004
  13. Ku J, Jung C, Hwang JH. Toxicological study of SU-Eohyeol Pharmacopuncture in an in vivo micronucleus test in SpragueDawley rats. Korean J Acupunct. 2022;39(2):54-62. https://doi.org/10.14406/acu.2022.008
  14. Ku J, Hwang JH. Genotoxicity evaluation using reversion mutation test of SU-Eohyeol pharmacopuncture. J Physiol Pathol Korean Med. 2022;36(4):113-9.
  15. Pessayre D, Larrey D, Biour M. Drug-induced liver injury. In: Bircher J, editor. Oxford textbook of clinical hepatology. Oxford: Oxford University Press; 1999. p. 1261-315.
  16. Ministry of Food and Drug Safety. Good Laboratory Practice Regulation for Nonclinical Laboratory Studies (Notification No. 2018-93) [Internet]. Cheongju: Ministry of Food and Drug Safety; 2018 Nov 21 [cited 2022 Jun 1]. Available from: https://www.law.go.kr/LSW/admRulLsInfoP.do?admRulSeq=2100000170349.
  17. Organization for Economic Co-operation and Development (OECD). ENV/MC/CHEM(98)17: OECD Series on Principles of Good Laboratory Practice and Compliance Monitoring Number 1 [Internet]. Paris: OECD; 1998 [cited 2022 Jun 1]. Available from: https://one.oecd.org/document/ENV/MC/CHEM(98)17/en/pdf.
  18. Lee DJ, Hwangbo M, Kwon K, Seo HS. Review of cervi cornu parvum pharmacopuncture in Korean medicine. J Pharmacopuncture. 2013;16(2):7-14.
  19. Lee YM. Introduction to evidence based medicine. J Korean Soc Vasc Surg. 2003;19(2):212-9.
  20. Lee B, Choi Y, Kim PW, Yang C, Lee MS. Regulation and status of herbal medicine clinical trials in Korea: a narrative review. Integr Med Res. 2021;10(2):100688. https://doi.org/10.1016/j.imr.2020.100688
  21. National Institute of Food and Drug Safety Evaluation (NIFDS). Herbal Medicine (Crude Drug) Formulation_Non-clinical Trial_Guideline (Complainant's Guideline) [Internet]. Cheongju: NIFDS; 2017 Sep 1 [cited 2022 Jun 1]. Available from: https://www.nifds.go.kr/brd/m_15/view.do?seq=11381&srchFr=&srchTo=&srchWord=%ED%95%9C%EC%95%BD&srchTp=0&itm_seq_1=0&itm_seq_2=0&multi_itm_seq=0&company_cd=&company_nm=&page=2.
  22. Kim JH, Ahn IY, Noh JY, Park SE, Yi JS, Koh KY, et al. Recent trend of international guidelines for genotoxicity testing. Regul Res Food Drug Cosmet. 2016;11(2):201-9
  23. Ko YS, Yun SH, Kim MK, Song YS, Shin BC. Literatural study on toxicity of herbs used in . Korean J Orient Physiol Pathol. 2005;19(5):1120-8.
  24. Lee YJ, Hwang WD, Lee JW, Jeong HJ, Bae SH, Kim KG. The study of safety of herbal medicine including Fuzi(附子) on high range of LFT, RFT patients. Korean J Orient Med Prescr. 2011;19(2):179-89.
  25. Park YC, Park HM, Lee SD. Inducible mechanisms for hepatotoxicity caused by traditional Korean medicines in a view of toxicology. J Korean Orient Med. 2011;32(4):48-67.